glp 1 drugs fda approved Medicare covers GLP-1s for $50/month starting July 2026 Comparing Ozempic, Wegovy and Other

Are you at least 18 years old

[DOI] [PubMed] [Google Scholar] 20.Damman K, Testani JM

2830 In addition to its glucose- and weight-lowering efficacy, semaglutide, when used as add-on standard care in patients with T2DM and high cardiovascular disease, was found to be associated with significantly lower risk of cardiovascular death, nonfatal myocardial infarction, stroke and new or worsening nephropathy compared to placebo

Research suggests Abbys concern about rebound weight gain is well founded

Youll need to coordinate with your provider to pick up the medication from their office

Zepbound (tirzepatide): Patients on the 15 mg dose lost an average of 21% of their body weight over 72 weeks